{"id":6594,"date":"2023-09-12T03:40:46","date_gmt":"2023-09-12T03:40:46","guid":{"rendered":"https:\/\/expresorgv.online\/home\/?p=6594"},"modified":"2023-09-12T03:40:48","modified_gmt":"2023-09-12T03:40:48","slug":"aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario","status":"publish","type":"post","link":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/","title":{"rendered":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario"},"content":{"rendered":"\n<p>La aprobaci\u00f3n por parte de<strong>la Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios de la terapia Amivantamab<\/strong>\u00a0permitir\u00e1 tratar a pacientes adultos con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) avanzado o metast\u00e1sico con mutaciones gen\u00e9ticas.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>\u201cLa aprobaci\u00f3n de esta nueva terapia tiene especial relevancia debido a que, actualmente el c\u00e1ncer de pulm\u00f3n es la enfermedad que tiene la m\u00e1s alta tasa de mortalidad<\/strong> tanto en hombres como en mujeres y es responsable de aproximadamente 18% de todas las muertes por c\u00e1ncer a nivel global\u201d, explic\u00f3 Santiago Posada, director M\u00e9dico y Regulatorio para Janssen M\u00e9xico.<\/p>\n<\/blockquote>\n\n\n\n<p><strong>La patolog\u00eda se divide en dos tipos, el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as y el c\u00e1ncer de pulm\u00f3n<\/strong> de c\u00e9lulas no peque\u00f1as; este \u00faltimo representa alrededor del 85% de los casos\u201d, agreg\u00f3.<\/p>\n\n\n\n<p><strong>La gravedad se incrementa porque la mayor\u00eda de los pacientes son diagnosticados en etapas avanzadas de la enfermedad,<\/strong> cuando el c\u00e1ncer ha hecho met\u00e1stasis y esto limita las opciones terap\u00e9uticas que se pueden ofrecer a los pacientes. El diagn\u00f3stico diferenciado, incluyendo un testeo molecular completo para identificar mutaciones gen\u00e9ticas espec\u00edficas, se ha convertido en una herramienta esencial en la toma de decisiones m\u00e9dicas ya que permite a los especialistas dise\u00f1ar estrategias de tratamiento altamente dirigidas y personalizadas desde el inicio, maximizando las oportunidades de \u00e9xito terap\u00e9utico y reduciendo posibles efectos secundarios innecesarios\u201d, detall\u00f3 Posada.<\/p>\n\n\n\n<p><strong>La medicina de precisi\u00f3n es un enfoque innovador en el campo de la salud que busca proporcionar tratamientos m\u00e1s personalizados<\/strong> y efectivos a los pacientes a trav\u00e9s de la identificaci\u00f3n de las mutaciones gen\u00e9ticas de cada individuo y, en la idea de que cada paciente es \u00fanico y por lo tanto el tratamiento m\u00e1s efectivo puede variar de una persona a otra.<\/p>\n\n\n\n<p><strong>La investigaci\u00f3n especializada permite un mejor diagn\u00f3stico a trav\u00e9s de biomarcadores espec\u00edficos que identifican con exactitud el tipo de c\u00e1ncer,<\/strong> dando oportunidad de abordar con innovaci\u00f3n a la enfermedad mediante medicina de precisi\u00f3n para atacar la mutaci\u00f3n espec\u00edfica y mejorar los resultados del tratamiento para los pacientes.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>\u201cEstamos convencidos que traer estas alternativas que realmente se ajusten a las necesidades individuales de cada uno de los pacientes les va a transformar la vida. Llevamos d\u00e9cadas estudiando e investigando para poder hacer del c\u00e1ncer una enfermedad prevenible, f\u00e1cilmente diagnosticable, interceptable, tratable y eventualmente podamos hablar de la cura\u201d, dijo.<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>La aprobaci\u00f3n por parte dela Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios de la terapia Amivantamab\u00a0permitir\u00e1 tratar a pacientes adultos con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) avanzado o metast\u00e1sico con mutaciones gen\u00e9ticas. \u201cLa aprobaci\u00f3n de esta nueva terapia tiene especial relevancia debido a que, actualmente el c\u00e1ncer de pulm\u00f3n es la [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":6564,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-6594","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nacional"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario\" \/>\n<meta property=\"og:description\" content=\"La aprobaci\u00f3n por parte dela Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios de la terapia Amivantamab\u00a0permitir\u00e1 tratar a pacientes adultos con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) avanzado o metast\u00e1sico con mutaciones gen\u00e9ticas. \u201cLa aprobaci\u00f3n de esta nueva terapia tiene especial relevancia debido a que, actualmente el c\u00e1ncer de pulm\u00f3n es la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-12T03:40:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-12T03:40:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"810\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"expreso\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"expreso\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\"},\"author\":{\"name\":\"expreso\",\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\"},\"headline\":\"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario\",\"datePublished\":\"2023-09-12T03:40:46+00:00\",\"dateModified\":\"2023-09-12T03:40:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\"},\"wordCount\":446,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1\",\"articleSection\":[\"NACIONAL\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\",\"url\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\",\"name\":\"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario -\",\"isPartOf\":{\"@id\":\"https:\/\/expresorgv.online\/home\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1\",\"datePublished\":\"2023-09-12T03:40:46+00:00\",\"dateModified\":\"2023-09-12T03:40:48+00:00\",\"author\":{\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\"},\"breadcrumb\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1\",\"width\":810,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/expresorgv.online\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/expresorgv.online\/home\/#website\",\"url\":\"https:\/\/expresorgv.online\/home\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/expresorgv.online\/home\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\",\"name\":\"expreso\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"caption\":\"expreso\"},\"url\":\"https:\/\/expresorgv.online\/home\/blog\/author\/expreso\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/","og_locale":"es_ES","og_type":"article","og_title":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario","og_description":"La aprobaci\u00f3n por parte dela Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios de la terapia Amivantamab\u00a0permitir\u00e1 tratar a pacientes adultos con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) avanzado o metast\u00e1sico con mutaciones gen\u00e9ticas. \u201cLa aprobaci\u00f3n de esta nueva terapia tiene especial relevancia debido a que, actualmente el c\u00e1ncer de pulm\u00f3n es la [&hellip;]","og_url":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/","article_published_time":"2023-09-12T03:40:46+00:00","article_modified_time":"2023-09-12T03:40:48+00:00","og_image":[{"width":810,"height":450,"url":"https:\/\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png","type":"image\/png"}],"author":"expreso","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"expreso","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#article","isPartOf":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/"},"author":{"name":"expreso","@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2"},"headline":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario","datePublished":"2023-09-12T03:40:46+00:00","dateModified":"2023-09-12T03:40:48+00:00","mainEntityOfPage":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/"},"wordCount":446,"commentCount":0,"image":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1","articleSection":["NACIONAL"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/","url":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/","name":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario -","isPartOf":{"@id":"https:\/\/expresorgv.online\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage"},"image":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1","datePublished":"2023-09-12T03:40:46+00:00","dateModified":"2023-09-12T03:40:48+00:00","author":{"@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2"},"breadcrumb":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#primaryimage","url":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1","contentUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1","width":810,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/expresorgv.online\/home\/blog\/2023\/09\/12\/aprueba-cofepris-molecula-para-tratar-cancer-de-pulmon-hereditario\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/expresorgv.online\/home\/"},{"@type":"ListItem","position":2,"name":"Aprueba Cofepris mol\u00e9cula para tratar c\u00e1ncer de pulm\u00f3n hereditario"}]},{"@type":"WebSite","@id":"https:\/\/expresorgv.online\/home\/#website","url":"https:\/\/expresorgv.online\/home\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/expresorgv.online\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2","name":"expreso","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","caption":"expreso"},"url":"https:\/\/expresorgv.online\/home\/blog\/author\/expreso\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2023\/09\/120923CancerPulmon.png?fit=810%2C450&ssl=1","_links":{"self":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/6594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/comments?post=6594"}],"version-history":[{"count":1,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/6594\/revisions"}],"predecessor-version":[{"id":6595,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/6594\/revisions\/6595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/media\/6564"}],"wp:attachment":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/media?parent=6594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/categories?post=6594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/tags?post=6594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}